Effects of the PAR-1 Antagonist Vorapaxar on Platelet Activation and Coagulation Biomarkers in Patients with Stable Coronary Artery Disease

Renske H Olie*, Paola E J van der Meijden, Henri M H Spronk, Rene van Oerle, Stale Barvik, Vernon V S Bonarjee, Hugo Ten Cate, Dennis W T Nilsen

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)e259-e262
Number of pages4
JournalTH open : companion journal to thrombosis and haemostasis
Issue number3
Publication statusPublished - Jul 2019

Cite this